|
|
| | Myristoyl-Lys-Arg-Thr-Leu-Arg-OH Basic information |
| Product Name: | Myristoyl-Lys-Arg-Thr-Leu-Arg-OH | | Synonyms: | n-myristoyl-lysyl-arginyl-threonyl-leucyl-arginine;MYRISTOYL-KRTLR-OH;MYRISTOYL-LYS-ARG-THR-LEU-ARG;N-M-KRTLR;N-MYRISTOYL-LYS-ARG-THR-LEU-ARG-OH;MYRISTOYL-LYS-ARG-THR-LEU-ARG: MYRISTOYL-KRTLR;L-Arginine, N2-(1-oxotetradecyl)-L-lysyl-L-arginyl-L-threonyl-L-leucyl-;29:PN:WO2011083481 SEQID:29 claimed protein | | CAS: | 125678-68-4 | | MF: | C42H82N12O8 | | MW: | 883.18 | | EINECS: | | | Product Categories: | | | Mol File: | 125678-68-4.mol |  |
| | Myristoyl-Lys-Arg-Thr-Leu-Arg-OH Chemical Properties |
| | Myristoyl-Lys-Arg-Thr-Leu-Arg-OH Usage And Synthesis |
| Uses | N-Myristoyl-Lys-Arg-Thr-Leu-Arg is a protein kinase C (PKC) inhibitor with an IC50 value of 75 μM. N-Myristoyl-Lys-Arg-Thr-Leu-Arg inhibits IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat[1]. | | References | [1] Ioannides CG, et, al. Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C. Cell Immunol. 1990 Nov;131(1):242-52. DOI:10.1016/0008-8749(90)90250-u |
| | Myristoyl-Lys-Arg-Thr-Leu-Arg-OH Preparation Products And Raw materials |
|